XBIT ▼ -0.5% - XBiotech Inc. $XBIT - XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cancer 19-OCT-2026 09:00 AM ET